Delayed Recognition of Deterioration

Failure to timely recognize, report, and escalate deteriorating patient conditions, leading to delayed intervention.

6 items 1 source 1 inquiry
Source spread

Where this theme appears

Delayed Recognition of Deterioration has been flagged across 1 independent accountability source:

6 inquiry recs

This theme has been identified in one data source. As more data is added, cross-references may emerge.

Browse by source

Source-grouped records are useful for tracing where a concern came from. Large sections show the 50 strongest matches for that source; counts still show the full theme total.

IBI-6a(vi) — Commissioning Hepatology Services
Infected Blood Inquiry
Recommendation: All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those bodies responsible for commissioning hepatology services in each of the home nations should publish the steps they have taken to satisfy …
Gov response: UK Government We accept this recommendation but will balance its implementation against NHS England’s role to promote equitable access for all, the principle that patients should receive the same treatment irrespective of how the disease …
Accepted No update 2+ yrs
IBI-6a(v) — Consultant Hepatologist Access
Infected Blood Inquiry
Recommendation: All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have had Hepatitis C which is attributable to infected blood or blood products should be seen by a consultant hepatologist, …
Gov response: UK Government We accept this recommendation but will balance its implementation against NHS England’s role to promote equitable access for all, the principle that patients should receive the same treatment irrespective of how the disease …
Accepted in Part No update 2+ yrs
IBI-6a(iv) — Fibroscan for Liver Imaging
Infected Blood Inquiry
Recommendation: All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Fibroscan technology should be used for liver imaging, rather than alternatives
Gov response: UK Government We accept this recommendation but will balance its implementation against NHS England’s role to promote equitable access for all, the principle that patients should receive the same treatment irrespective of how the disease …
Accepted No update 2+ yrs
IBI-6a(iii) — Uncertainty About Fibrosis
Infected Blood Inquiry
Recommendation: All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Where there is any uncertainty about whether a patient has fibrosis they should receive the same care
Gov response: UK Government We accept this recommendation but will balance its implementation against NHS England’s role to promote equitable access for all, the principle that patients should receive the same treatment irrespective of how the disease …
Accepted No update 2+ yrs
IBI-6a(ii) — Specialist Hepatology Centre Access
Infected Blood Inquiry
Recommendation: All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have fibrosis should receive the same care
Gov response: UK Government We accept this recommendation but will balance its implementation against NHS England’s role to promote equitable access for all, the principle that patients should receive the same treatment irrespective of how the disease …
Accepted in Part No update 2+ yrs
IBI-6a(i) — Hepatologist Oversight and Fibroscan Access
Infected Blood Inquiry
Recommendation: All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have been diagnosed with cirrhosis at any point should receive lifetime monitoring by way of six-monthly fibroscans and annual clinical …
Gov response: UK Government We accept this recommendation but will balance its implementation against NHS England’s role to promote equitable access for all, the principle that patients should receive the same treatment irrespective of how the disease …
Accepted No update 2+ yrs